I know I hate "shoulda, coulda, woulda's". If this works out like I think it will, we'll be sittin pretty soon enough.
Subsidiary to launch brilacdin in the U.S. and E.U. And very likely brilacidin-UPS as well.
Just getting the wheels rolling again will be awesome. I still think the start of an actual trial is months away. But when/if the funding comes through in the form of a licensing, I doubt we'll be sitting under the $.
Message in reply to:
BD....I am not at all negative on IPIX's prospects. I think accumulation in the 20-22 price zone will be a good buying opportunity. And the approximate 2 million shares the MFO bought to provide the $400,000 capital raise for this month will give us an opportunity to buy at 1/2 the recent high.
"Perfection is not attainable, but if we chase perfection we can catch excellence." Vince Lombardi Do your research! Play the TA. All posts are my opinion.